Orthocell Orthocell is a company that develops devices for regenerating mobility of tendon, cartilage, and soft tissue. | ![]() Celldex Therapeutics Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development. | |
Founding Date | Founding Date 2006 | Founding Date 1983 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Murdoch, AU HQ | Locations Hampton, US HQ Fall River, US Needham, US New Haven, US |
Employees | Employees N/A | Employees 1608% increase |
Valuation ($) | Valuation ($) 65.5 m | Valuation ($) 1.9 b |
Financial | ||
Revenue (est.) | Revenue (est.) $7.6m (FY, 2025) | Revenue (est.) $1.5m (FY, 2025) |
Cost of goods | Cost of goods $2.2m (FY, 2025) | Cost of goods $200k (FY, 2025) |
Gross profit | Gross profit $5.7m (FY, 2025) | Gross profit $1.3m (FY, 2025) |
Net income | Net income ($8.6m) (FY, 2025) | Net income ($258.8m) (FY, 2025) |

Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development.
View company